Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

This study has been withdrawn prior to enrollment.
(Sponsor preferred a better study design)
Sponsor:
Information provided by (Responsible Party):
Mesoblast, Ltd.
ClinicalTrials.gov Identifier:
NCT00810212
First received: December 17, 2008
Last updated: November 6, 2014
Last verified: October 2008
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: November 2011
  Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)